Literature DB >> 748093

Clinical significance of serum bile acid measurement in liver diseases.

T Morita, Y Matsuyama, T Fujimoto, M Higuchi, T Tsujii, Y Matsuoka.   

Abstract

To determine the clinical significance of serum bile acid measurements, changes in the serum bile acid composition in liver diseases and endogenous bile acid clearance due to test meal loads were investigated. In the case of changes in the serum bile acid composition, a characteristic pattern of a remarkable increase of chenodeoxycholic acid (CDCA) was found in fulminant hepatitis. In patients with acute hepatitis, increases in CDCA were somewhat greater than those of cholic acid (CA) and there was tendency for these changes to precede changes in other liver function tests. In cases of extrahepatic obstructive jaundice, the CA/CDCA ratio was a large value exceeding 1.0. In investigations of endogenous bile acid clearance, serum bile acid concentration two hours after the text meal load clearly reflected the hepatic disorder and it was useful in differentiating between active and inactive form in chronic hepatitis and compensation and decompensation in liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 748093     DOI: 10.1007/bf02774915

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  16 in total

1.  MEASUREMENT OF HUMAN SERUM BILE ACIDS BY GAS-LIQUID CHROMATOGRAPHY.

Authors:  D H SANDBERG; J SJOEVALL; K SJOEVALL; D A TURNER
Journal:  J Lipid Res       Date:  1965-04       Impact factor: 5.922

2.  Bile acids in the serum of jaundiced patients.

Authors:  J B CAREY
Journal:  Gastroenterology       Date:  1961-09       Impact factor: 22.682

3.  A simple and sensitive assay of total serum bile acids.

Authors:  F Mashige; K Imai; T Osuga
Journal:  Clin Chim Acta       Date:  1976-07-01       Impact factor: 3.786

4.  A fluorimetric and enzymatic method for the estimation of serum total bile acids.

Authors:  G M Murphy; B H Billing; D N Baron
Journal:  J Clin Pathol       Date:  1970-10       Impact factor: 3.411

5.  Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.

Authors:  M G Korman; A F Hofmann; W H Summerskill
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

6.  Postprandial serum bile acid for the detection of hepatobiliary disease.

Authors:  N Kaplowitz; E Kok; N B Javitt
Journal:  JAMA       Date:  1973-07-16       Impact factor: 56.272

7.  Radioimmunoassay of conjugated cholyl bile acids in serum.

Authors:  W J Simmonds; M G Korman; V L Go; A F Hofmann
Journal:  Gastroenterology       Date:  1973-11       Impact factor: 22.682

8.  Serum bile acid concentration after a test meal.

Authors:  O Fausa
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

9.  Quantitative determination of serum bile acids using a purified 3 alpha-hydroxysteroid dehydrogenase.

Authors:  O Fausa
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

10.  Total plasma bile acid concentration in chronic hepatitis and cirrhosis; fasting values and effect of intraduodenal bile salt administration.

Authors:  B Franz; J C Bode
Journal:  Klin Wochenschr       Date:  1974-06-01
View more
  5 in total

1.  Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.

Authors:  Y Adachi; T Nanno; T Itoh; Y Kurumi; K Yamazaki; Y Sawada; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1988-08

2.  Clinical usefulness of serum cholylglycine determination in various liver diseases.

Authors:  Y Tanggo; S Fujiyama; F Kin; A Tashiro; H Shiraoku; M Akahoshi; Y Sato; O Hashiguchi; K Sagara
Journal:  Gastroenterol Jpn       Date:  1982-10

3.  Clinical value of serum bile acid levels in chronic hepatitis.

Authors:  M B Jones; S Weinstock; R L Koretz; K J Lewin; J Higgins; G L Gitnick
Journal:  Dig Dis Sci       Date:  1981-11       Impact factor: 3.199

4.  Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity.

Authors:  MaryPeace McRae; Naser L Rezk; Arlene S Bridges; Amanda H Corbett; Hsiao-Chuan Tien; Kim L R Brouwer; Angela D M Kashuba
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705

5.  Extensive alterations of blood metabolites in pediatric cerebral malaria.

Authors:  Sanchit Gupta; Karl Seydel; Miguel A Miranda-Roman; Catherine M Feintuch; Alex Saidi; Ryung S Kim; Gretchen L Birbeck; Terrie Taylor; Johanna P Daily
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.